Smith & Nephew (SN.)

Sector:

Health Care

Index:

FTSE 100

1,084.50p
   
  • Change Today:
      14.00p
  • 52 Week High: 1,425.00
  • 52 Week Low: 1,018.50
  • Currency: UK Pounds
  • Shares Issued: 872.51m
  • Volume: 341,670
  • Market Cap: £9,462m
  • RiskGrade: 173

Smith and Nephew Overview

Medical devices group Smith & Nephew makes nearly half of its revenues through its orthopaedics division, which manufactures knee joints, braces and other supports. Established in 1931, the group now has interests all over the world.
Competitors: Synthes Acc.Inv. Sf-,001, Stryker, Johnson & Johnson, Zimmer Biomet Holdings Inc
Registrars: Equiniti
Brands: profix, cofield

Key Personnel

Senior Independent Director: Robin Freestone
CEO: Deepak Nath
CFO & Executive Director: Anne-Francoise  Nesmes
Chairman: Roberto Quarta
Independent Non-Executive Director: Angie Risley
Independent Non-Executive Director: Jo Hallas
Independent Non-Executive Director: Bob White
Independent Non-Executive Director: Marc Owen
Independent Non-Executive Director: Erik Engstrom
Independent Non-Executive Director: Katarzyna Mazur Hofsaess
Independent Non-Executive Director: Rick Medlock
Independent Non-Executive Director: John Ma
Non-Executive Dir:

Contact Details

Address: Building 5, Croxley Park, Hatters Lane, Watford, Hertfordshire, United Kingdom, WD18 8YE
Phone: +44 (0)1923 477100
Fax: +44 (0) 20 7960 2350
Website: http://www.smith-nephew.com

Listings

Sector: Health Care(LSE)
Index: techMARK, FTSE 100, FTSEurofirst 300, FTSE 350, FTSE All-Share, FTSE techMARK Focus
Overseas Listings: BATSLON:SNL
ISIN: GB0009223206

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Smith and Nephew Market Data

Currency UK Pounds
Share Price 1,084.50p
Change Today 14.00p
% Change 1.31 %
52 Week High 1,425.00
52 Week Low 1,018.50
Volume 341,670
Shares Issued 872.51m
Market Cap £9,462m
RiskGrade 173

Smith and Nephew Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
71.12% below the market average71.12% below the market average71.12% below the market average71.12% below the market average71.12% below the market average
57.89% above the sector average57.89% above the sector average57.89% above the sector average57.89% above the sector average57.89% above the sector average
Price Trend Not Available
Income
9.91% below the market average9.91% below the market average9.91% below the market average9.91% below the market average9.91% below the market average
80.00% above the sector average80.00% above the sector average80.00% above the sector average80.00% above the sector average80.00% above the sector average
Growth
10.25% below the market average10.25% below the market average10.25% below the market average10.25% below the market average10.25% below the market average
37.14% below the sector average37.14% below the sector average37.14% below the sector average37.14% below the sector average37.14% below the sector average

What The Brokers Say

Strong Buy 5
Buy 1
Neutral 6
Sell 0
Strong Sell 1
Total 13
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Smith and Nephew Dividends

  Latest Previous
  Interim Final
Ex-Div 29-Sep-22 31-Mar-22
Paid 26-Oct-22 11-May-22
Amount 14.40¢ 23.10¢

Trades for 08-Aug-2022

Time Volume / Share Price
14:19 177 @ 1,084.50p
14:19 86 @ 1,084.50p
14:19 215 @ 1,084.50p
14:18 79 @ 1,084.00p
14:17 262 @ 1,084.00p

Smith and Nephew Key Personnel

Chair Roberto Quarta
CEO Deepak Nath

Top of Page